Deals channel feed

Tang Cap­i­tal con­tin­ues biotech buy­ing spree with ac­qui­si­tion bid for Rain On­col­o­gy

Last year

Op­ti­miz­eRx builds out pa­tient DTC mar­ket­ing with $95M ac­qui­si­tion

Last year
Pharma
Marketing

BioN­Tech sends $70M to an­oth­er ADC part­ner to go up against Dai­ichi Sankyo in HER3

Last year
China
Pharma

#Eu­ro­Bio23: The down­turn, tak­ing risks and the ‘biotech mafia’

Last year
People
Financing

As­tria nabs pre­clin­i­cal OX40 atopic der­mati­tis drug for $15M up­front, prices $64M of­fer­ing

Last year
Financing

Il­lu­mi­na re­ceives EU or­der to di­vest Grail

Last year
Diagnostics

Sanofi adds an­oth­er AI al­liance, this time for bi­o­log­ics with Baidu CEO’s start­up

Last year
China
AI

Anap­tys­Bio touts PhI­II win in a rare form of pso­ri­a­sis. But it does­n't plan on keep­ing the drug

Last year
R&D

Up­dat­ed: GSK taps Chi­nese part­ner to ramp up Shin­grix sales in $3.05B deal, with op­tion to ex­pand to RSV

Last year
China

Bris­tol My­ers makes a $4.8B bet on KRAS, strik­ing deal to ac­quire Mi­rati

Last year

Am­gen clos­es $28B Hori­zon ac­qui­si­tion a month af­ter FTC bat­tle end­ed

Last year
Pharma

Ab­cam lays out de­tails be­hind $5.7B Dana­her ac­qui­si­tion, takeover at­tempts by founder and for­mer CEO

Last year
People

Lon­za boosts ADC sup­ply ca­pac­i­ty through part­ner­ship ex­pan­sion with un­named ma­jor phar­ma

Last year
Manufacturing

Gene ther­a­py mak­er Or­chard Ther­a­peu­tics sells to Ky­owa Kirin for $387M cash as lead pro­gram awaits 2024 FDA ver­dict

Last year
Cell/Gene Tx

EQRx had lim­it­ed buy­er in­ter­est, tried ac­quir­ing oth­er com­pa­nies be­fore Rev­o­lu­tion came for its cash

Last year

So­ma­Log­ic, Stan­dard BioTools to merge in­to $1B mul­ti-omics tech provider

Last year
Manufacturing

Up­dat­ed: Sanofi's $1.5B pact with Te­va in IBD adds fu­el to an­ti-TL1A race against Mer­ck, Roivant and Pfiz­er

Last year

Eli Lil­ly to buy ra­dio­phar­ma com­pa­ny Point Bio­phar­ma for $1.4B as PhI­II read­out looms

Last year
Pharma

Sanofi slides J&J’s E. coli vac­cine in­to late-stage port­fo­lio, bet­ting $175M cash on de­vel­op­ment, com­mer­cial­iza­tion pact

Last year

Ex-Warp Speed vac­cine leader nabs NextGen funds for Mod­eX Ther­a­peu­tics’ Covid-19 an­ti­bod­ies

Last year
Coronavirus

Roche bets again on Io­n­is in Hunt­ing­ton’s, Alzheimer's

Last year

Ex­clu­sive: Pfiz­er, Gink­go sign R&D deal worth up to $331M to de­vel­op RNA drugs

Last year

In­ter­cept to sell in $800M cash buy­out af­ter sec­ond NASH re­jec­tion sank hopes

Last year

Take­da strikes $500M+ deal for Cal­i­for­nia biotech's ALS pro­gram

Last year
Pharma
First page Previous page 27282930313233 Next page Last page
A service from the Financial Times